SÉPSIS / SHOCK SÉPTICO

ISBN: 978-84-09-13786-2

AUTORES
Ana Arizcorreta Yarza
Rafael Sierra Camerino
Juan Benítez Macías
BIBLIOGRAFÍA
  • Levi MM, Evans >Le, and Rodes A. The surviving sepsis campaign bundle: 2018 update. Crit Care Med 2018; 46 (6): 997-1000.
  • Singer M, Deutschman CS, Seymour CW, Shankar-Hari M et al. Third international consensous definitions for sepsis and septic shock (sepsis-3). JAMA 2016; 315: 801-10.
  • Rodríguez RM, Greengood HG, Nuckton TJ, et al. Comparision of qSOFA with current emergency department tools for screening of patients with sepsis for critical illness. Emerg Med J 2018; 35: 350-356
  • Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39(2):165-228.
  • Derek C. Angus, Tom Var der Poll. Severe sepsis and septic shock. N Engl J Med 2013; 369: 840-51.
  • Retamar P, Portillo MM, López-Prieto MD, Rodriguez-López F, de Cueto M, Garcia MV et al. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 2012; 56: 472-78.
  • Paul M, Lador A, Grozinsky-Glasberg S, Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 2014; 1: CD003344.